Quantinno Capital Management LP raised its stake in Simulations Plus, Inc. (NASDAQ:SLP – Free Report) by 439.1% during the 1st quarter, HoldingsChannel reports. The firm owned 112,259 shares of the technology company’s stock after acquiring an additional 91,434 shares during the period. Quantinno Capital Management LP’s holdings in Simulations Plus were worth $1,327,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also modified their holdings of SLP. First Light Asset Management LLC boosted its holdings in shares of Simulations Plus by 33.7% in the first quarter. First Light Asset Management LLC now owns 2,632,823 shares of the technology company’s stock valued at $31,120,000 after acquiring an additional 663,906 shares in the last quarter. Ameriprise Financial Inc. lifted its position in Simulations Plus by 25.3% in the second quarter. Ameriprise Financial Inc. now owns 875,447 shares of the technology company’s stock valued at $15,277,000 after purchasing an additional 176,747 shares during the period. Marshall Wace LLP lifted its position in Simulations Plus by 127.5% in the fourth quarter. Marshall Wace LLP now owns 569,783 shares of the technology company’s stock valued at $10,387,000 after purchasing an additional 319,301 shares during the period. Stephens Investment Management Group LLC boosted its holdings in Simulations Plus by 30.8% in the 4th quarter. Stephens Investment Management Group LLC now owns 513,728 shares of the technology company’s stock valued at $9,365,000 after purchasing an additional 120,888 shares in the last quarter. Finally, First Eagle Investment Management LLC boosted its holdings in Simulations Plus by 1,898.1% in the 4th quarter. First Eagle Investment Management LLC now owns 457,155 shares of the technology company’s stock valued at $8,334,000 after purchasing an additional 434,275 shares in the last quarter. Institutional investors and hedge funds own 78.08% of the company’s stock.
Simulations Plus Stock Performance
Simulations Plus stock opened at $18.31 on Friday. The stock has a fifty day moving average of $17.98 and a two-hundred day moving average of $15.29. The company has a market capitalization of $370.41 million, a price-to-earnings ratio of 45.77 and a beta of 1.32. Simulations Plus, Inc. has a fifty-two week low of $11.09 and a fifty-two week high of $21.01.
Wall Street Analyst Weigh In
A number of analysts recently weighed in on SLP shares. Craig Hallum downgraded Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 price target on the stock. in a research note on Thursday, June 18th. William Blair downgraded Simulations Plus from an “outperform” rating to a “market perform” rating in a report on Wednesday, June 17th. Weiss Ratings upgraded shares of Simulations Plus from a “sell (d)” rating to a “sell (d+)” rating in a research report on Friday, July 10th. Finally, Wall Street Zen cut shares of Simulations Plus from a “buy” rating to a “hold” rating in a research note on Saturday, June 13th. Seven analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Reduce” and a consensus price target of $17.25.
Check Out Our Latest Stock Analysis on Simulations Plus
Insider Transactions at Simulations Plus
In other Simulations Plus news, Director Walter S. Woltosz sold 4,177 shares of Simulations Plus stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $18.44, for a total value of $77,023.88. Following the completion of the sale, the director directly owned 3,202,131 shares of the company’s stock, valued at approximately $59,047,295.64. The trade was a 0.13% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 19.10% of the company’s stock.
About Simulations Plus
Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.
Further Reading
- Five stocks we like better than Simulations Plus
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Want to see what other hedge funds are holding SLP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Simulations Plus, Inc. (NASDAQ:SLP – Free Report).
Receive News & Ratings for Simulations Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Simulations Plus and related companies with MarketBeat.com's FREE daily email newsletter.
